| Net Cash Provided by (Used in) Operating Activities |
$234,000,000 |
USD |
|
Q1 2024 |
Q1 2024 |
| Net Cash Provided by (Used in) Financing Activities |
$3,286,000,000 |
USD |
159% |
Q1 2024 |
Q1 2024 |
| Net Cash Provided by (Used in) Investing Activities |
$1,846,000,000 |
USD |
-83% |
Q1 2024 |
Q1 2024 |
| Common Stock, Shares Authorized |
2,500,000 |
shares |
0% |
Q3 2024 |
Q3 2024 |
| Common Stock, Shares, Issued |
2,500,000 |
shares |
0% |
Q3 2024 |
Q3 2024 |
| Common Stock, Par or Stated Value Per Share |
1 |
USD/shares |
0% |
Q3 2024 |
Q3 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$1,674,000,000 |
USD |
595% |
Q1 2024 |
Q1 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$2,408,000,000 |
USD |
135% |
Q3 2024 |
Q3 2024 |
| Deferred Tax Assets, Valuation Allowance |
$1,000,000 |
USD |
|
Q3 2024 |
Q3 2024 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$1,407,000,000 |
USD |
877% |
Q3 2024 |
Q3 2024 |
| Additional Paid in Capital |
$1,885,000,000 |
USD |
0.16% |
Q3 2024 |
Q3 2024 |
| Depreciation, Depletion and Amortization |
$142,000,000 |
USD |
992% |
Q1 2024 |
Q1 2024 |